search
Back to results

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities (SUCCEED)

Primary Purpose

Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
SUCCEED Community-Based Intervention
Sponsored by
London School of Hygiene and Tropical Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Schizophrenia focused on measuring Sub-Saharan Africa, Psychosis, Co-Production, Peer support, Human rights, Nigeria, Malawi, Zimbabwe, Sierra Leone, Pilot trial, Schizophrenia, Community-based rehabilitation, Livelihoods

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: Participants with lived experience of psychosis must: Be consenting/assenting adults (age 18+) Be able to speak one of the main study languages: English, Chichewa, Krio, Shona, Yoruba Live within the pilot study area Have a current or past diagnosis of schizophrenia or other primary psychotic disorder, bipolar or depressive disorder with psychotic symptoms, or a maternal mental health or behavioural disorder with psychotic symptoms, as per the World Health Organisation's International Classification of Diseases Version 11 (see full list of eligible diagnoses, below). For participants recruited from within the health care system, diagnosis will be confirmed from health records. For those identified in the community, a research worker will administer the World Health Organisation's Composite International Diagnostic Interview (WHO CIDI) screening tool for psychosis. The following diagnoses are eligible for inclusion: Schizophrenia (6A20) Schizoaffective disorder (6A21) Schizotypal disorder (6A22) Acute and transient psychotic disorder (6A23) Delusional disorder (6A24) Other specified (6A2Y) or unspecified (6A2Z) primary psychotic disorder Bipolar type I disorder with psychotic symptoms (6A60.1, 6A60.5, 6A60.7, 6A60.A) Bipolar type II disorder with psychotic symptoms (6A61.3, 6A61.5) Single episode depressive disorder with psychotic symptoms (6A70.2, 6A70.4) Recurrent depressive disorder with psychotic symptoms (6A71.2, 6A71.4) Mental or behavioural disorder associated with pregnancy, childbirth or the puerperium, with psychotic symptoms (6E21) Exclusion Criteria: People who are currently homeless, for logistical reasons; the SUCCEED intervention relies on PSWs and CSWs being able to regularly contact participants, including for home visits. People with secondary psychotic syndromes (6E61), as these are considered to be the direct consequences of physical health conditions as opposed to mental health conditions. People diagnosed with a substance-induced psychotic disorder (6C40.6-6C47.6), as recovery from substance use conditions is a specialist area outside the scope of the SUCCEED intervention under development.

Sites / Locations

  • Kamuzu University of Health Sciences
  • University of Ibadan
  • University of MakeniRecruiting
  • University of ZimbabweRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

SUCCEED Community-Based Intervention

Arm Description

The SUCCEED community-based intervention (offering a combination of peer support, case management and livelihoods activities) will be delivered to 10 participants with lived experience of psychosis at each of the 4 pilot sites.

Outcomes

Primary Outcome Measures

Change in self-reported Quality of Life (World Health Organisation Quality of Life Questionnaire Brief Version)
WHOQOL-BREF has 26 items assessing individual's perception of their well-being over previous 2 weeks, across four domains (physical, psychological, social relationships and environment). Response to each item is rated against a 5-point Likert scale (1=not at all and 5=large amount). Scores are linearly transformed to total out of 100 where higher scores indicate better quality of life. WHOQOL-BREF may be administered by a data collector in an interview format or self-completed (with data collector available for any assistance needed). We will also invite a close family member to complete the WHOQOL-BREF independently at baseline to investigate reliability of self- versus proxy-reported quality of life. Both participants with lived experience of psychosis and family members will be asked to complete a cognitive interview checking understanding of the questionnaire following completion of the WHOQOL-BREF at baseline.

Secondary Outcome Measures

Full Information

First Posted
July 20, 2023
Last Updated
August 17, 2023
Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
University of Ibadan, University of Malawi, University of Makeni, University of Zimbabwe, Zimbabwe National Association for Mental Health (ZIMNAMH), Mental Health Users and Carers Association (MeHUCA) Malawi, The Asido Foundation, Mental Health Coalition Sierra Leone
search

1. Study Identification

Unique Protocol Identification Number
NCT06007105
Brief Title
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities
Acronym
SUCCEED
Official Title
SUCCEED Africa: Protocol for a Multi-method Pilot Study of a Community-based Intervention for People With Psychosis in West and Southeast Africa
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 18, 2023 (Actual)
Primary Completion Date
December 15, 2023 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
University of Ibadan, University of Malawi, University of Makeni, University of Zimbabwe, Zimbabwe National Association for Mental Health (ZIMNAMH), Mental Health Users and Carers Association (MeHUCA) Malawi, The Asido Foundation, Mental Health Coalition Sierra Leone

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Although psychotic disorders typically affect less than 1% of the population, they are a significant cause of disability worldwide. Psychotic symptoms such as hallucinations, delusions and suicidal ideation can be profoundly disturbing, and negatively impact daily living. However, the social consequences of psychosis are often even more troubling than the symptoms. For example, people with psychosis have a high risk of experiencing violence, poverty, homelessness, incarceration, and unemployment, among other adverse outcomes. There is a need for a range of accessible, appropriate interventions for people with psychosis to be delivered to those in the most vulnerable situations, including in low-resource settings in sub-Saharan Africa. A systematic review recently carried out as part of the formative research for SUCCEED identified 10 studies evaluating the impact of interventions for people with psychosis in Africa, most of which had a strongly clinical focus. The review concluded that there was a need for further research involving people with lived experience of psychosis in designing and evaluating holistic interventions that meet their diverse needs, within and beyond the health sector. SUCCEED Africa is a six-year Health Research Programme Consortium (RPC) that has brought together people with lived experience of psychosis and people with professional experience (researchers, clinicians) from four African countries (Malawi, Nigeria, Sierra Leone, Zimbabwe) to co-produce a community-based intervention for psychosis, using a Theory of Change-driven approach. The SUCCEED intervention takes the World Health Organisation's (WHO's) CBR Matrix as a point of departure to consider the multifaceted needs of people living with psychosis and other psychosocial disabilities, and how best to meet these needs by mobilising the resources of individuals and families affected, as well as their broader communities. This protocol describes a pilot study in which the SUCCEED intervention will be delivered and evaluated on a small scale, in preparation for a larger multi-country research evaluation using more rigorous methods, including randomised controlled trials in Nigeria and Zimbabwe and observational studies in Malawi and Sierra Leone, respectively. The main outcome of interest is change in subjective quality of life among participants with lived experience of psychosis who are offered the intervention over a four-month follow up period.
Detailed Description
Recognising the need for a framework for interventions to support people with psychosocial disabilities in LMICs, the WHO's 2010 CBR Guidelines included a special supplement on mental health, which drew mainly from expert opinion, evidence in community mental health, and basic development principles, to make recommendations for best practice. However, a 2016 review examining CBR for disabilities in LMICs identified only one example of CBR for psychosocial disabilities in Sub-Saharan Africa. The authors concluded that there was a need for more evidence from this region, in particular. As part of SUCCEED Africa's formative research, a systematic review of the grey literature on CBR for psychosocial disabilities in LMICs was undertaken, in case there was in fact evidence available that had been excluded as a result of the previous review's strict eligibility criteria. The grey literature review identified 33 different CBR programmes, 11 of which were based in sub-Saharan Africa, but the quality of the evidence was generally very poor and too heterogeneous for any sort of meta-analysis. In contrast to previous reviews, the grey literature review found that the majority of programmes were not focused primarily on health, covering more domains of the CBR Matrix (e.g. livelihoods, empowerment, education, etc.). This suggests a disconnect between how CBR programmes are designed and evaluated to optimise clinical outcomes for research purposes, versus how they are designed to meet pragmatic needs in real-world practice. The SUCCEED pilot will use a before-and-after study design looking at changes in subjective quality of life (WHOQOL-BREF) among participants with lived experience of psychosis who are offered the SUCCEED intervention over a four-month follow-up period. Key components of the SUCCEED intervention are peer support, case management and livelihoods activities, which are delivered by a gender-mixed team including one peer support worker and one community support worker embedded in a local organisation for persons with disabilities (OPD) in each SUCCEED country. Nested within this pilot are three other components, described further in the full research protocol (available upon request) : A baseline assessment of the feasibility and acceptability of WHOQOL-BREF as a measurement tool (time taken to administer, proportion of participants who complete the tool, perspectives of data collectors assessed through interviews), face validity (assessed through cognitive interviewing) of WHOQOL-BREF, and the validity of proxy (completed by a close family member) versus self-completion. A qualitative study using a combination of focus groups (participants with psychosis, family members) and interviews (peer support workers, community support workers, supervisors, data collectors) to further examine the acceptability and feasibility of the SUCCEED's research and M&E tools (including WHOQOL-BREF) and processes. A process evaluation drawing on semi-structured observations and routine monitoring and evaluation (M&E) of intervention delivery, competency assessment of the two frontline providers (peer support workers and community support workers, via ENACT) research administrative data (adverse events, drop-outs), and end-line qualitative data (see above) to assess key process indicators and implementation outcomes (e.g. acceptability, appropriateness, feasibility, fidelity, safety, etc.).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder, Acute and Transient Psychotic Disorder, Delusional Disorder, Other Specified or Unspecified Primary Psychotic Disorder, Bipolar Type I Disorder With Psychotic Symptoms, Bipolar Type II Disorder With Psychotic Symptoms, Single Episode Depressive Disorder With Psychotic Symptoms, Recurrent Depressive Disorder With Psychotic Symptoms, Perinatal Mental or Behavioural Disorder With Psychotic Symptoms
Keywords
Sub-Saharan Africa, Psychosis, Co-Production, Peer support, Human rights, Nigeria, Malawi, Zimbabwe, Sierra Leone, Pilot trial, Schizophrenia, Community-based rehabilitation, Livelihoods

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This is a four-country pilot using a before-and-after study design to measure change in quality of life using the 26-item WHOQOL-BREF in participants with lived experience of psychosis who are offered the SUCCEED intervention (including case management, peer support and livelihoods activities) over a four-month follow-up period.
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
SUCCEED Community-Based Intervention
Arm Type
Experimental
Arm Description
The SUCCEED community-based intervention (offering a combination of peer support, case management and livelihoods activities) will be delivered to 10 participants with lived experience of psychosis at each of the 4 pilot sites.
Intervention Type
Behavioral
Intervention Name(s)
SUCCEED Community-Based Intervention
Intervention Description
The main components of the intervention are peer support, case management and livelihoods activities, delivered by a peer support worker and a community support worker. The peer support worker has lived experience of psychosis and draws on a variety of manualised tools and techniques adapted from previous studies. The community support worker mobilises families and communities to activate resources in support of participants (e.g., education and employment, social and recreational activities), drawing on established models of mental health case management and community-based inclusive development. The peer support worker and community support worker also run self-help groups for people with lived experience and their family members, respectively. Self-help group meetings are also used as an opportunity for group livelihoods activities taking an "ABCD" (asset-based community development" approach.
Primary Outcome Measure Information:
Title
Change in self-reported Quality of Life (World Health Organisation Quality of Life Questionnaire Brief Version)
Description
WHOQOL-BREF has 26 items assessing individual's perception of their well-being over previous 2 weeks, across four domains (physical, psychological, social relationships and environment). Response to each item is rated against a 5-point Likert scale (1=not at all and 5=large amount). Scores are linearly transformed to total out of 100 where higher scores indicate better quality of life. WHOQOL-BREF may be administered by a data collector in an interview format or self-completed (with data collector available for any assistance needed). We will also invite a close family member to complete the WHOQOL-BREF independently at baseline to investigate reliability of self- versus proxy-reported quality of life. Both participants with lived experience of psychosis and family members will be asked to complete a cognitive interview checking understanding of the questionnaire following completion of the WHOQOL-BREF at baseline.
Time Frame
Baseline and at 4 months follow up (endpoint)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Participants with lived experience of psychosis must: Be consenting/assenting adults (age 18+) Be able to speak one of the main study languages: English, Chichewa, Krio, Shona, Yoruba Live within the pilot study area Have a current or past diagnosis of schizophrenia or other primary psychotic disorder, bipolar or depressive disorder with psychotic symptoms, or a maternal mental health or behavioural disorder with psychotic symptoms, as per the World Health Organisation's International Classification of Diseases Version 11 (see full list of eligible diagnoses, below). For participants recruited from within the health care system, diagnosis will be confirmed from health records. For those identified in the community, a research worker will administer the World Health Organisation's Composite International Diagnostic Interview (WHO CIDI) screening tool for psychosis. The following diagnoses are eligible for inclusion: Schizophrenia (6A20) Schizoaffective disorder (6A21) Schizotypal disorder (6A22) Acute and transient psychotic disorder (6A23) Delusional disorder (6A24) Other specified (6A2Y) or unspecified (6A2Z) primary psychotic disorder Bipolar type I disorder with psychotic symptoms (6A60.1, 6A60.5, 6A60.7, 6A60.A) Bipolar type II disorder with psychotic symptoms (6A61.3, 6A61.5) Single episode depressive disorder with psychotic symptoms (6A70.2, 6A70.4) Recurrent depressive disorder with psychotic symptoms (6A71.2, 6A71.4) Mental or behavioural disorder associated with pregnancy, childbirth or the puerperium, with psychotic symptoms (6E21) Exclusion Criteria: People who are currently homeless, for logistical reasons; the SUCCEED intervention relies on PSWs and CSWs being able to regularly contact participants, including for home visits. People with secondary psychotic syndromes (6E61), as these are considered to be the direct consequences of physical health conditions as opposed to mental health conditions. People diagnosed with a substance-induced psychotic disorder (6C40.6-6C47.6), as recovery from substance use conditions is a specialist area outside the scope of the SUCCEED intervention under development.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dr Julian Eaton
Phone
+44 77 11140365
Email
julian.eaton@lshtm.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Grace Ryan
Phone
+44 7943224203
Email
grace.ryan@lshtm.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Professor Thomas Shakespeare
Organizational Affiliation
London School of Hygiene and Tropical Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kamuzu University of Health Sciences
City
Blantyre
State/Province
Southern
ZIP/Postal Code
0000
Country
Malawi
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Janet Mambulasa
Phone
+265888894836
Email
jmambulasa@kuhes.ac.mw
First Name & Middle Initial & Last Name & Degree
Anthony Sefasi
Facility Name
University of Ibadan
City
Ibadan
State/Province
Oyo State
ZIP/Postal Code
0000
Country
Nigeria
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dr Rita Tamambang
Phone
+234 8036811452
Email
ritzfri@yahoo.com
First Name & Middle Initial & Last Name & Degree
Prof Olayinka Omigbodun
Facility Name
University of Makeni
City
Makeni
State/Province
Northen Province
ZIP/Postal Code
0000
Country
Sierra Leone
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Veronica Ramatu Kamara
Phone
+232 79020049
Email
veroalpha001@gmail.com
First Name & Middle Initial & Last Name & Degree
Dr Rebecca Esliker
Facility Name
University of Zimbabwe
City
Harare
State/Province
North East
ZIP/Postal Code
0000
Country
Zimbabwe
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ephiphania Munetsi
Phone
+263 777028347
Email
epimunetsi1@gmail.com
First Name & Middle Initial & Last Name & Degree
Prof Dixon Chibanda

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Only anonymised data will be uploaded for archiving and data sharing. SUCCEED Data Access and Publication Policy stipulates that data are jointly owned by all SUCCEED partners; thus all partners are free to access anonymised SUCCEED data. Access is facilitated by the Data Management Team, which is comprised of nominated researchers at each site.
IPD Sharing Time Frame
After an 18-month embargo period, data are prepared for upload to LSHTM Data Compass site, in line with FCDO UK guidance on data sharing.
IPD Sharing Access Criteria
Any individual internal or external to SUCCEED may submit an expression of interest using a standardised online form outlining their intention to access and/or publish SUCCEED data; expressions of interest are reviewed on a regular basis by SUCCEED's five-country leadership team for approval. This is the main avenue by which SUCCEED ensures the use of data is for valid research. Once approved, those accessing the project data are required to sign a data access/confidentiality form.
IPD Sharing URL
https://datacompass.lshtm.ac.uk/information.html
Citations:
PubMed Identifier
36618745
Citation
Hunt X, Abdurahman H, Omobowale O, Afolayan A, Munetsi E, Dzapasi L, Mokaya N, Koroma A, Barrie I, Ogunmola O, Koroma A, Shakespeare T, Eaton J, Ryan G. Interventions for adolescents and adults with psychosis in Africa: a systematic review and narrative synthesis. Glob Ment Health (Camb). 2022 May 27;9:223-240. doi: 10.1017/gmh.2022.25. eCollection 2022.
Results Reference
background
PubMed Identifier
36978186
Citation
Omigbodun OO, Ryan GK, Fasoranti B, Chibanda D, Esliker R, Sefasi A, Kakuma R, Shakespeare T, Eaton J. Reprioritising global mental health: psychoses in sub-Saharan Africa. Int J Ment Health Syst. 2023 Mar 28;17(1):6. doi: 10.1186/s13033-023-00574-x.
Results Reference
background
PubMed Identifier
37306804
Citation
Bella-Awusah T, Abdurahman H, Omobowale O, Aturu O, Afolayan A, Ogunmola O, Fasoranti B, Olusanmi M, Tamambang R, Bamidele O, Ryan G, Shakespeare T, Eaton J, Omigbodun O. Lessons of Hope and Resilience: A Co-Produced Qualitative Study of the Experiences of Youth Living with Psychosis During the COVID-19 Pandemic in Nigeria. Community Ment Health J. 2023 Jun 12:1-13. doi: 10.1007/s10597-023-01128-8. Online ahead of print.
Results Reference
background
PubMed Identifier
36939989
Citation
Lee YY, Buyanga M, Mehta A, Omowunmi OA, Ryan G, Sunkel C, Vasquez A, Jones N. Cracks that Let the Light in: Collective Reflections on Integrating Lived Experience of Psychosis in Research and Policy in the Context of a Global Commission. Community Ment Health J. 2023 Jul;59(5):819-825. doi: 10.1007/s10597-023-01118-w. Epub 2023 Mar 20.
Results Reference
background
Links:
URL
https://www.lshtm.ac.uk/research/centres-projects-groups/succeed
Description
Study webpage

Learn more about this trial

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

We'll reach out to this number within 24 hrs